Every processed story in chronological order, with the newest coverage first. Filter by tag, source, or score to drill in.
RHO demonstrates that AI agents can meaningfully self-improve their harness without any labeled validation data, removing a key bottleneck for deploying and continuously optimizing agents in practical settings.
Developers and practitioners building AI for life sciences should note that Noetik's platform-licensing deal with GSK signals that pharma companies are beginning to pay for biotech AI as software infrastructure, not just as a path to drug co-development — validating a pure-tools business model in the space.